日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Low risk of severe COVID-19 in vaccinated people with multiple sclerosis: a nationwide Norwegian study

一项挪威全国性研究表明,接种疫苗的多发性硬化症患者感染新冠病毒后发展为重症的风险较低。

Rasmussen, Tilde Harridsleff; Schikora-Rustad, Stine; Lorentzen, Åslaug Rudjord; Tran, The Trung; Øverås, Mathias H; Myhr, Kjell-Morten; Wergeland, Stig; Aarseth, Jan; Bø, Lars; Berge, Tone; Høgestøl, Einar August; Harbo, Hanne F; Tveter, Anne Therese; Jørgensen, Kristin Kaasen; Cunen, Celiné; Torkildsen, Øivind; Holmøy, Trygve; Celius, Elisabeth Gulowsen; Vaage, John Torgils; Nygaard, Gro Owren; Lund-Johansen, Fridtjof; König, Marton

Dynamics of SARS-CoV-2 immunity after vaccination and breakthrough infection in rituximab-treated rheumatoid arthritis patients: a prospective cohort study

利妥昔单抗治疗的类风湿性关节炎患者接种疫苗后SARS-CoV-2免疫力及突破性感染的动态变化:一项前瞻性队列研究

Kared, Hassen; Jyssum, Ingrid; Alirezaylavasani, Amin; Egner, Ingrid M; The Tran, Trung; Tietze, Lisa; Lund, Katrine Persgård; Tveter, Anne Therese; Provan, Sella A; Ørbo, Hilde; Haavardsholm, Espen A; Vaage, John Torgils; Jørgensen, Kristin; Syversen, Silje Watterdal; Lund-Johansen, Fridtjof; Goll, Guro Løvik; Munthe, Ludvig A

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations

多发性硬化症患者对SARS-CoV-2 mRNA疫苗的体液免疫:上次利妥昔单抗输注后的时间以及首次零星重复接种疫苗的经验的相关性

König, Marton; Lorentzen, Åslaug Rudjord; Torgauten, Hilde Marie; Tran, The Trung; Schikora-Rustad, Stine; Vaage, Eline Benno; Mygland, Åse; Wergeland, Stig; Aarseth, Jan; Aaberge, Ingeborg Aase S; Torkildsen, Øivind; Holmøy, Trygve; Berge, Tone; Myhr, Kjell-Morten; Harbo, Hanne Flinstad; Andersen, Jan Terje; Munthe, Ludvig Andre; Søraas, Arne; Celius, Elisabeth Gulowsen; Vaage, John Torgils; Lund-Johansen, Fridtjof; Nygaard, Gro Owren

Humoral Response After 6 or More Successive Doses of SARS-CoV-2 mRNA Vaccines in Kidney Transplant Recipients-Should We Keep Vaccinating?

肾移植受者连续接种 6 剂或更多剂 SARS-CoV-2 mRNA 疫苗后的体液免疫反应——我们应该继续接种疫苗吗?

Åsberg, Anders; Hovd, Markus; Kjellevold, Stig Arne; Stenehjem, Aud-E; Wien, Tale Norbye; Broch, Lars Ulrik; Reier-Nielsen, Morten; Qvale, Tor Hatlestad; Marti, Hans-Peter; Heldal, Kristian; Bitter, Jan; Hagelsteen Kvien, Elisabeth; Vaage, John Torgils; Lund-Johansen, Fridtjof; Midtvedt, Karsten

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination

在患有多发性硬化症且接种 COVID-19 疫苗后免疫反应较弱的患者中,第三剂 SARS-CoV-2 疫苗的免疫原性和安全性

König, Marton; Torgauten, Hilde Marie; Tran, The Trung; Holmøy, Trygve; Vaage, John Torgils; Lund-Johansen, Fridtjof; Nygaard, Gro Owren

Humoral and cellular immune responses to two and three doses of SARS-CoV-2 vaccines in rituximab-treated patients with rheumatoid arthritis: a prospective, cohort study

利妥昔单抗治疗的类风湿性关节炎患者接种两剂和三剂SARS-CoV-2疫苗后的体液和细胞免疫反应:一项前瞻性队列研究

Jyssum, Ingrid; Kared, Hassen; Tran, Trung T; Tveter, Anne T; Provan, Sella A; Sexton, Joseph; Jørgensen, Kristin K; Jahnsen, Jørgen; Kro, Grete B; Warren, David J; Vaage, Eline B; Kvien, Tore K; Nissen-Meyer, Lise-Sofie H; Anderson, Ane Marie; Grødeland, Gunnveig; Haavardsholm, Espen A; Vaage, John Torgils; Mjaaland, Siri; Syversen, Silje Watterdal; Lund-Johansen, Fridtjof; Munthe, Ludvig A; Goll, Guro Løvik

The persistence of anti-Spike antibodies following two SARS-CoV-2 vaccine doses in patients on immunosuppressive therapy compared to healthy controls-a prospective cohort study

一项前瞻性队列研究比较了接受免疫抑制治疗的患者与健康对照组在接种两剂SARS-CoV-2疫苗后抗刺突蛋白抗体的持久性。

Christensen, Ingrid Egeland; Jyssum, Ingrid; Tveter, Anne Therese; Sexton, Joseph; Tran, Trung T; Mjaaland, Siri; Kro, Grete Birkeland; Kvien, Tore K; Warren, David John; Jahnsen, Jørgen; Munthe, Ludvig A; Haavardsholm, Espen A; Vaage, John Torgils; Grødeland, Gunnveig; Lund-Johansen, Fridtjof; Jørgensen, Kristin Kaasen; Syversen, Silje Watterdal; Goll, Guro Løvik; Provan, Sella Aarrestad

Fourth dose of the SARS-CoV-2 vaccine in kidney transplant recipients with previously impaired humoral antibody response

肾移植受者既往体液抗体反应受损,接种第四剂SARS-CoV-2疫苗

Midtvedt, Karsten; Vaage, John Torgils; Heldal, Kristian; Munthe, Ludvig A; Lund-Johansen, Fridtjof; Åsberg, Anders

Breakthrough infections with the omicron and delta variants of SARS-CoV-2 result in similar re-activation of vaccine-induced immunity.

SARS-CoV-2 的 omicron 和 delta 变种的突破性感染会导致疫苗诱导的免疫力发生类似的重新激活

Søraas Arne, Grødeland Gunnveig, Granerud Beathe Kiland, Ueland Thor, Lind Andreas, Fevang Børre, Murphy Sarah L, Huse Camilla, Nygaard Anders Benteson, Steffensen Anne Katrine, Al-Baldawi Huda, Holberg-Petersen Mona, Andresen Lise Lima, à gnes Camilla, Ranheim Trine, Schanke Ylva, Istre Mette, Dahl John Arne, Chopra Adity, Dudman Susanne, Kaarbø Mari, Andersen Jan Terje, Vaage Eline Benno, Tran Trung The, Vaage John Torgils, Michelsen Annika E, Müller Fredrik, Aukrust Pål, Halvorsen Bente, Dahl Tuva B, Holter Jan Cato, Lund-Johansen Fridtjof

Immunogenicity and safety of a three-dose SARS-CoV-2 vaccination strategy in patients with immune-mediated inflammatory diseases on immunosuppressive therapy

在接受免疫抑制治疗的免疫介导炎症性疾病患者中,三剂SARS-CoV-2疫苗接种策略的免疫原性和安全性

Syversen, Silje Watterdal; Jyssum, Ingrid; Tveter, Anne Therese; Sexton, Joe; Christensen, Ingrid Egeland; Tran, Trung T; Bjørlykke, Kristin Hammersbøen; Mjaaland, Siri; Warren, David J; Kvien, Tore K; Chopra, Adity; Kro, Grete Birkeland; Jahnsen, Jorgen; Munthe, Ludvig A; Haavardsholm, Espen A; Grødeland, Gunnveig; Vaage, John Torgils; Provan, Sella Aarrestad; Jørgensen, Kristin Kaasen; Goll, Guro Løvik